Ekso Bionics
EKSO
P/S ratio for Ekso Bionics (EKSO)
P/S ratio as of June 2024 (TTM): 1.07
According to Ekso Bionics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.06532. At the end of 2023 the company had a P/S ratio of 1.95.
P/S ratio history for Ekso Bionics from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.95 | 60.74% |
| 2022 | 1.21 | -59.41% |
| 2021 | 2.98 | -48% |
| 2020 | 5.74 | 135.01% |
| 2019 | 2.44 | -64.56% |
| 2018 | 6.89 | -60.29% |
| 2017 | 17.4 | 183.37% |
| 2016 | 6.12 | -50.57% |
| 2015 | 12.4 | -52.25% |
| 2014 | 25.9 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 STAAR Surgical STAA | 7.04 | 561.15% | 🇺🇸 USA |
 OraSure Technologies OSUR | 1.02 | -3.83% | 🇺🇸 USA |
 AtriCure ATRC | 2.72 | 155.12% | 🇺🇸 USA |
 Biolase
BIOL | 0.0494 | -95.36% | 🇺🇸 USA |